Avg closing price
Price range

2 David Einhorn Talis Biomedical Trades

David Einhorn acquired 2.24 Million Talis Biomedical shares worth $1.4 Million. That's 0.11% of their equity portfolio (31st largest holding). The investor owns 8.74% of the outstanding Talis Biomedical stock. The investor's estimated purchase price is $9.36 Million, resulting in a loss of 85%.

Avg closing price
Price range
Increased shares by 42.5% (+666 Thousand shares) Q1 2022
Avg closing price $2.31
Price range $1.30 - $4.19
New holding (+1.57 Million shares) Q4 2021
Avg closing price $4.99
Price range $3.81 - $6.17

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!